Rethinking osteoporosis: balancing risk and benefit in diagnosis, prevention, and treatment

JAAPA. 2013 Aug;26(8):20-7. doi: 10.1097/01.jaa.0000432496.47021.62.

Abstract

The standard of care for osteoporosis is changing amid questions about the long-term safety and efficacy of curren drugs for preventing and treating osteoporosis. This article provides a guide for evidence-based treatment, but not over-treatment, as well as the selection and duration of available drug therapies.

MeSH terms

  • Bone Density Conservation Agents / therapeutic use
  • Humans
  • Life Style
  • Osteoporosis / diagnosis*
  • Osteoporosis / etiology
  • Osteoporosis / therapy*
  • Osteoporotic Fractures / etiology
  • Osteoporotic Fractures / prevention & control*
  • Risk Factors
  • Risk Reduction Behavior

Substances

  • Bone Density Conservation Agents